Disease/Infection News

RSS

Potential new treatment approach to fatal COVID-19

Researchers from the University of Colorado Anschutz Medical Campus and Pathways Bioscience in the United States have found that activating a transcription factor involved in oxidative stress regulation, antiviral activity, and inflammation may serve as a new treatment approach to coronavirus disease 2019 (COVID-19).

18 May 2020

SMART researchers awarded NMRC funding to develop rapid paper-based COVID-19 tests

Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, has received a grant from the National Medical Research Council COVID-19 Research fund for the acceleration of research and development of rapid paper-based serological and diagnostic tests for COVID-19.

18 May 2020

Novel insights on SARS-CoV-2 cell entry may inform further vaccine and treatment development

A research group from Harvard Medical School reported two cryo-electron microscopy structures derived from a single preparation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein in their paper available on the preprint server bioRxiv. Understanding the nuances of prefusion and postfusion conformations shed light on viral cell entry and may, in turn, guide the development of vaccines and drugs.

18 May 2020

Cross-neutralization of SARS and COVID-19 coronaviruses by a monoclonal antibody

An antibody first identified in a blood sample from a patient who recovered from Severe Acute Respiratory Syndrome in 2003 inhibits related coronaviruses, including the cause of COVID-19.

18 May 2020

Asthma linked to longer intubation time in younger COVID-19 patients

New data suggest that asthma is associated with longer time on ventilators for hospitalized younger patients with COVID-19.

18 May 2020

New algorithms support doctors in making a faster and accurate diagnosis

The know-how from the world's top experts in lung ultrasound was collected and organized in the software application.

18 May 2020

Study aims to identify markers that predict how COVID-19 affects patients

COVID-19 is the UK's largest public health crisis since World War II. There is an urgent need to identify why some patients with the virus do very well whereas others need to be admitted to intensive care and may die from the disease.

18 May 2020

Tourists, beware: Foreign visitors’ travel health insurance might exclude pandemics

It was evident that the fever, nausea and loss of appetite Vlastimil Gajdoš felt on his wedding day was not a mere case of cold feet.

18 May 2020

In the COVID age, bring a mask and gloves to a protest

When Lamari Edwards joined Dreasjon "Sean" Reed's Facebook Live video, she could sense something bad was going to happen, but she never thought she was witnessing the last moments of her friend's life. "I had a bad feeling, but I did not think it would end this way," said Edwards.

18 May 2020

Drugmakers tout COVID-19 vaccines to refurbish their public image

Johnson & Johnson researchers working on a vaccine against the coronavirus are "just like the heroes in the hospitals" fighting to save patients, J&J CEO Alex Gorsky said on the "Today" show a few weeks ago.

18 May 2020

COVID-19 may lead to thrombosis in the lungs and subsequently multi organ failure

COVID-19, the disease caused by SARS-CoV-2, not only may lead to severe pneumonia but also to thrombosis in the lungs and, subsequently, to multi organ failure involving kidneys, liver and pancreas.

18 May 2020

ISE continues to support research community in the global effort to fight COVID-19

The current COVID-19 pandemic is having a huge impact on people across the globe and in these unprecedented times we consider it more important than ever that we continue to support the publication of relevant and timely research.

18 May 2020

Medicaid providers at the end of the line for federal COVID funding

Casa de Salud, a nonprofit clinic in Albuquerque, New Mexico, provides primary medical care, opioid addiction services and non-Western therapies, including acupuncture and reiki, to a largely low-income population.

18 May 2020

New biodegradable antiviral filters developed for protective masks

The CSIC's associated unit in Polymer Technology in Castellón will study the biodegradation levels of the materials developed.

18 May 2020

Researchers are developing advanced measures to fight against COVID-types contagions

A research team from the University of Valencia, led by the professor of the Department of Computer Science Pedro Morillo, is developing a project to improve protection against infections in areas of high availability of health centres.

18 May 2020

Avacta's SARS-COV-2 neutralizing Affimer reagents show therapeutic potential for COVID-19

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that several of the Affimer reagents recently generated for development of a point-of-care COVID-19 antigen saliva test have now also been shown to block the interaction between the virus’ spike protein and ACE2, a receptor on human cells that is key to the virus infection pathway.

From Avacta Life Sciences Ltd. 18 May 2020

COVID-19 clinical trials show positive early results, says GlobalData

With the number of COVID-19 cases and deaths increasing with each passing day, the need for a therapeutic or a vaccine for the pandemic intensifies.

18 May 2020

Research explores how human enzymes could be used to exacerbate COVID-19

Centenary Institute researchers have examined the critical role of human enzymes and the coronavirus in a newly published scientific review article that explores potential strategies for COVID-19 disease treatment and management.

18 May 2020

Interactive "Netflix" type platform for educators affected by COVID-19

The World Literacy Foundation announced today the development of an interactive "Netflix" type platform to equip educators with resources that have been affected by the indefinite school lockdown as a result of COVID-19.

18 May 2020

A novel approach to predict heart damage in COVID-19 patients

Johns Hopkins researchers recently received a $195,000 Rapid Response Research grant from the National Science Foundation to, using machine learning, identify which COVID-19 patients are at risk of adverse cardiac events such as heart failure, sustained abnormal heartbeats, heart attacks, cardiogenic shock and death.

18 May 2020

Disease/Infection News

Potential new treatment approach to fatal COVID-19

SMART researchers awarded NMRC funding to develop rapid paper-based COVID-19 tests

Novel insights on SARS-CoV-2 cell entry may inform further vaccine and treatment development

Cross-neutralization of SARS and COVID-19 coronaviruses by a monoclonal antibody

Asthma linked to longer intubation time in younger COVID-19 patients

New algorithms support doctors in making a faster and accurate diagnosis

Study aims to identify markers that predict how COVID-19 affects patients

Tourists, beware: Foreign visitors’ travel health insurance might exclude pandemics

In the COVID age, bring a mask and gloves to a protest

Drugmakers tout COVID-19 vaccines to refurbish their public image

COVID-19 may lead to thrombosis in the lungs and subsequently multi organ failure

ISE continues to support research community in the global effort to fight COVID-19

Medicaid providers at the end of the line for federal COVID funding

New biodegradable antiviral filters developed for protective masks

Researchers are developing advanced measures to fight against COVID-types contagions

Avacta's SARS-COV-2 neutralizing Affimer reagents show therapeutic potential for COVID-19

COVID-19 clinical trials show positive early results, says GlobalData

Research explores how human enzymes could be used to exacerbate COVID-19

Interactive "Netflix" type platform for educators affected by COVID-19

A novel approach to predict heart damage in COVID-19 patients

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News